Blood Screening Market Scenario
Rising prevalence of infectious diseases and introduction of newer pathogens, technological advancements in the field of blood screening and increasing demand for donated blood and rising number of blood donations are some of the major factors propelling the blood screening market globally. Furthermore, rising blood donations and government initiatives is also one of the factor propelling the growth of blood screening market. However, stringent regulatory approvals is one of the major factor expected to hamper the global growth of the blood screening market.
Blood Screening Market Segmentation
The Blood Screening Market is segmented by Product & Service, Technology, End User and Geography. Various Product & Service of blood screening market are Reagents & Kits (NAT Reagents & Kits, Elisa Reagents & Kits and Other Reagents), Instruments and Software & Services. Furthermore, the Technologies studied in the report are Nucleic Acid Testing (NAT) (Transcription-Mediated Amplification and Real-Time Polymerase Chain Reaction (PCR)), Enzyme-Linked Immunosorbent Assays (Chemiluminescence Immunoassays, Fluorescent Immunoassays and Colorimetric Immunoassays), Rapid Tests, Western Blot Assays and Next-Generation Sequencing. Likewise, various End Users of this market are Blood Banks and Hospitals. Based on Geography, the Blood screening Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Blood Screening Market by Geography
Geographically, the blood screening market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America dominated the global blood screening market in 2019. The presence of key industry players, increased adoption of blood screening process, stringent FDA regulations for transfusion, and greater patient affordability are responsible for maintaining its position during the forecast period.
Blood Screening Market Key Players
Some of the major players operating in the global blood screening market includes Grifols, F. Hoffmann-La Roche, Abbott Laboratories, BioMérieux, Bio-Rad Laboratories, Becton, Dickson and Company, Danaher Corporation, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, DiaSorin, GE Healthcare, Merck KGaA, Perkinelmer, Bio-Techne, GFE, Trinity Biotech and J. Mitra Diagnostics Pvt. Ltd. c. These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.
Blood Screening Market Report Key Benefits